NCT00123669View on ClinicalTrials.gov

Primary Progesterone Therapy for Operable Breast Cancer

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

October 31, 1997

Primary Completion Date

May 29, 2020

Study Completion Date

May 29, 2020

Conditions
Breast Neoplasms
Interventions
DRUG

500 mg of depot hydroxy-progesterone

An intramuscular injection of 500 mg of depot hydroxy-progesterone 5 to 15 days prior to surgery.

Trial Locations (1)

400012

Tata Memorial Hospital, Mumbai

All Listed Sponsors
collaborator

Ministry of Science and Technology, India

OTHER_GOV

lead

Tata Memorial Hospital

OTHER_GOV

NCT00123669 - Primary Progesterone Therapy for Operable Breast Cancer | Biotech Hunter | Biotech Hunter